Perfil
Keith Barclay currently works at Caledonian Holdings Plc, as Investment Director from 2025.
Mr. Barclay also formerly worked at Elasmogen Ltd., as Director & Investor Director and Business Growth Fund Ltd, as Senior Investor from 2015 to 2024.
Mr. Barclay received his graduate degree from the University of Aberdeen.
Cargos activos de Keith Barclay
| Empresas | Cargo | Inicio |
|---|---|---|
| CALEDONIAN HOLDINGS PLC | Director de Inversiones | 01/08/2025 |
Antiguos cargos conocidos de Keith Barclay.
| Empresas | Cargo | Fin |
|---|---|---|
Business Growth Fund Ltd
Business Growth Fund Ltd Investment ManagersFinance Business Growth Fund Invests in companies located in the United Kingdom and Ireland. The firm targets companies operating in the fields of acquisitions, internationalisation, technology, data and AI sectors. It provides financing for growth and early stage capital requirement with an investment size of GBP 3 - 30 million. It act as a minority investor and makes follow-on investments. | Inversor de Capital Privado | 01/01/2024 |
Elasmogen Ltd.
Elasmogen Ltd. Pharmaceuticals: MajorHealth Technology Develops soloMER products for treatment of auto-immune mediated and inflammatory diseases | Director de Inversiones | - |
Formación de Keith Barclay.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 4 |
|---|---|
Vela Technologies Plc
Vela Technologies Plc Financial ConglomeratesFinance Operates as an investment company | Finance |
University of Aberdeen
University of Aberdeen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Business Growth Fund Ltd
Business Growth Fund Ltd Investment ManagersFinance Business Growth Fund Invests in companies located in the United Kingdom and Ireland. The firm targets companies operating in the fields of acquisitions, internationalisation, technology, data and AI sectors. It provides financing for growth and early stage capital requirement with an investment size of GBP 3 - 30 million. It act as a minority investor and makes follow-on investments. | Finance |
Elasmogen Ltd.
Elasmogen Ltd. Pharmaceuticals: MajorHealth Technology Develops soloMER products for treatment of auto-immune mediated and inflammatory diseases | Health Technology |
- Bolsa de valores
- Insiders
- Keith Barclay
















